Tailored online personal health record cancer tool increases survivor adherence to national guidelines

byRegenstrief InstituteScreenshot of personal health record, “My Follow-up Care” Dashboard. CEA: carcinoembryonic antigen; CT: computed tomography. Credit:JMIR Cancer(2022). DOI: 10.

Updated on: December 28,2023

Tailored online personal health record cancer tool increases survivor adherence to national guidelines

byRegenstrief InstituteScreenshot of personal health record, “My Follow-up Care” Dashboard. CEA: carcinoembryonic antigen; CT: computed tomography. Credit:JMIR Cancer(2022). DOI: 10.

Updated on:December 28,2023

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on: January 08,2024

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on:January 08,2024

Drug dramatically reduces risk of dangerous blood clots in cancer patients

by The Ottawa HospitalBlood clots in the legs can cause swelling, redness and pain. If a clot forms in the lungs, it can be deadly. New research provides the first approach for safely preventing these

Updated on: March 09,2024

Drug dramatically reduces risk of dangerous blood clots in cancer patients

by The Ottawa HospitalBlood clots in the legs can cause swelling, redness and pain. If a clot forms in the lungs, it can be deadly. New research provides the first approach for safely preventing these

Updated on:March 09,2024

European cancer epidemic could occur in next decade if health system weaknesses, cancer research not urgently addressed

byLancetKey findings of The Lancet Oncology Groundshot Commission. Credit: The LancetThe COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape ac

Updated on: January 02,2024

European cancer epidemic could occur in next decade if health system weaknesses, cancer research not urgently addressed

byLancetKey findings of The Lancet Oncology Groundshot Commission. Credit: The LancetThe COVID-19 pandemic has exposed weaknesses in cancer health systems and in the cancer research landscape ac

Updated on:January 02,2024

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

by Impact JournalsCaspase inhibitors (CI) selectively protect normal cells from chemotherapy-induced apoptosis, without protection multidrug-resistant cancer cells. Flavopiridol (shown in red, as a cy

Updated on: January 15,2024

Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells

by Impact JournalsCaspase inhibitors (CI) selectively protect normal cells from chemotherapy-induced apoptosis, without protection multidrug-resistant cancer cells. Flavopiridol (shown in red, as a cy

Updated on:January 15,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on: April 10,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on:April 10,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024

Topography of the genome influences where cancer mutations thrive, study shows

byUniversity of California - San DiegoJust as different terrains on Earth foster distinct ecosystems, certain topographic features in the genome seem to provide an environment for specific mutat

Updated on: January 22,2024

Topography of the genome influences where cancer mutations thrive, study shows

byUniversity of California - San DiegoJust as different terrains on Earth foster distinct ecosystems, certain topographic features in the genome seem to provide an environment for specific mutat

Updated on:January 22,2024

Identifying cancer genes' multiple personalities

byCold Spring Harbor LaboratoryAn up-close look at a mouse's liver; the cells with dark centers were turned cancerous using a new gene-editing strategy devised by Semir Beyaz's lab. Cred

Updated on: January 04,2024

Identifying cancer genes' multiple personalities

byCold Spring Harbor LaboratoryAn up-close look at a mouse's liver; the cells with dark centers were turned cancerous using a new gene-editing strategy devised by Semir Beyaz's lab. Cred

Updated on:January 04,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on: May 09,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on:May 09,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on: January 26,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on:January 26,2024

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Updated on: March 05,2024

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Updated on:March 05,2024